GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
NCT07627191
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Colorectal Cancer
Hepatocellular Carcinoma
Interventions
DRUG:
GLP1-RA (semaglutide)
Sponsor
University of Arizona